0001104659-20-122542.txt : 20201106
0001104659-20-122542.hdr.sgml : 20201106
20201106163215
ACCESSION NUMBER: 0001104659-20-122542
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200810
FILED AS OF DATE: 20201106
DATE AS OF CHANGE: 20201106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shah Rajeev M.
CENTRAL INDEX KEY: 0001619841
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38722
FILM NUMBER: 201294908
MAIL ADDRESS:
STREET 1: 200 BERKELEY STREET
STREET 2: 18TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kolchinsky Peter
CENTRAL INDEX KEY: 0001384859
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38722
FILM NUMBER: 201294909
MAIL ADDRESS:
STREET 1: 200 BERKELEY STREET
STREET 2: 18TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RA Capital Healthcare Fund LP
CENTRAL INDEX KEY: 0001315082
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38722
FILM NUMBER: 201294910
BUSINESS ADDRESS:
STREET 1: 200 BERKELEY STREET
STREET 2: 18TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6177782500
MAIL ADDRESS:
STREET 1: 200 BERKELEY STREET
STREET 2: 18TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER NAME:
FORMER CONFORMED NAME: RA Capital Biotech Fund LP
DATE OF NAME CHANGE: 20050121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RA CAPITAL MANAGEMENT, L.P.
CENTRAL INDEX KEY: 0001346824
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38722
FILM NUMBER: 201294911
BUSINESS ADDRESS:
STREET 1: 200 BERKELEY STREET, 18TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-778-2500
MAIL ADDRESS:
STREET 1: 200 BERKELEY STREET, 18TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER NAME:
FORMER CONFORMED NAME: RA CAPITAL MANAGEMENT, LLC
DATE OF NAME CHANGE: 20051213
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Orchard Therapeutics plc
CENTRAL INDEX KEY: 0001748907
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 108 CANNON STREET
CITY: LONDON
STATE: X0
ZIP: EC4N 6EU
BUSINESS PHONE: 011-44-0-203-3846700
MAIL ADDRESS:
STREET 1: 108 CANNON STREET
CITY: LONDON
STATE: X0
ZIP: EC4N 6EU
FORMER COMPANY:
FORMER CONFORMED NAME: Orchard Rx Ltd
DATE OF NAME CHANGE: 20180802
4
1
tm2035295-2_4.xml
OWNERSHIP DOCUMENT
X0306
4
2020-08-10
0
0001748907
Orchard Therapeutics plc
ORTX
0001346824
RA CAPITAL MANAGEMENT, L.P.
200 BERKELEY STREET, 18TH FLOOR
BOSTON
MA
02116
0
0
1
0
0001315082
RA Capital Healthcare Fund LP
200 BERKELEY STREET
BOSTON
MA
02116
0
0
1
0
0001384859
Kolchinsky Peter
C/O RA CAPITAL MANAGEMENT, L.P.
200 BERKELEY STREET, 18TH FLOOR
BOSTON
MA
02116
0
0
1
0
0001619841
Shah Rajeev M.
C/O RA CAPITAL MANAGEMENT, L.P.
200 BERKELEY STREET, 18TH FLOOR
BOSTON
MA
02116
0
0
1
0
Ordinary shares
2020-08-10
4
P
0
14570
4.75
A
9126418
I
See footnote
Ordinary shares
2020-08-10
4
P
0
6787
4.71
A
9133205
I
See footnote
Ordinary shares
2020-08-12
4
P
0
16291
4.74
A
9149496
I
See footnote
Ordinary shares
2020-08-14
4
P
0
13031
4.74
A
9162527
I
See footnote
Ordinary shares
2020-08-17
4
P
0
8235
4.74
A
9170762
I
See footnote
Ordinary shares
2020-08-18
4
P
0
45249
4.72
A
9216011
I
See footnote
Ordinary shares
2020-08-19
4
P
0
55204
4.69
A
9271215
I
See footnote
Ordinary shares
2020-08-19
4
P
0
9050
4.65
A
9280265
I
See footnote
Ordinary shares
2020-08-20
4
P
0
58106
4.61
A
9338371
I
See footnote
Ordinary shares
2020-08-20
4
P
0
4525
4.61
A
9342896
I
See footnote
Ordinary shares
2020-08-21
4
P
0
54416
4.64
A
9397312
I
See footnote
Ordinary shares
2020-08-21
4
P
0
10226
4.51
A
9407538
I
See footnote
Ordinary shares
2020-09-24
4
P
0
473327
4.61
A
9880865
I
See footnote
RA Capital Management, L.P. (the "Adviser") is the investment manager for the RA Capital Healthcare Fund, L.P. (the "Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The securities reported on this Form 4 are held directly by the Fund. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of such securities, except to the extent of any pecuniary interest therein.
This transaction was executed in multiple trades at prices ranging from $4.72 to $4.71; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer.
This transaction was executed in multiple trades at prices ranging from $4.75 to $4.70; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer.
This transaction was executed in multiple trades at prices ranging from $4.75 to $4.70; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer.
This transaction was executed in multiple trades at prices ranging from $4.70 to $4.65; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer.
This transaction was executed in multiple trades at prices ranging from $4.65 to $4.55; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer.
This transaction was executed in multiple trades at prices ranging from $4.47 to $4.70; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer.
This transaction was executed in multiple trades at prices ranging from $4.50 to $4.52; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer.
This transaction was executed in multiple trades at prices ranging from $4.57 to $4.71; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer.
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
2020-11-06
/s/ Peter Kolchinsky, Manager of RA Capital Healthcare GP, LLC, the General Partner of RA Capital Healthcare Fund, L.P.
2020-11-06
/s/ Peter Kolchinsky
2020-11-06
/s/ Rajeev Shah
2020-11-06